K Pharma,Inc. Stock

4896

JP3280900006

Pharmaceuticals

Delayed Japan Exchange 20:37:42 2026-10-04 EDT			5-day change	1st Jan Change
762.00 ^JPY	+1.60%		-4.87%	+15.45%

12-02	K Pharma,Inc. announced that it has received ¥1.5 billion in funding from Alfresa Holdings Corporation	CI
11-05	K Pharma,Inc. announced that it expects to receive ¥1.5 billion in funding from Alfresa Holdings Corporation	CI

K Pharma Inc is a Japan-based company mainly engaged in the pharmaceutical business. The Company operates through a single segment of research, development, manufacture, and sale of pharmaceuticals, among others. The Company is engaged in induced pluripotent stem cell (iPS) drug discovery business. Neural progenitor cells, the cells that form the basis of nerves, are created from iPS cells, cryopreserved, and then 200000 cells are transplanted by injection into the site of a patient's spinal cord injury. The Company is also engaged in the research, development, manufacture and sale of regenerative medicine products.

Employees

Sector

Pharmaceuticals

Calendar

11-12 Earnings release - Q3 2026

More about the company

Quotes

Date	Price	Change	Volume
26-10-04	JP¥762.00	+1.60%	6,500
26-10-02	JP¥750.00	-6.25%	48,200
26-10-01	JP¥800.00	-0.37%	6,600
26-09-30	JP¥803.00	+1.77%	7,600
26-09-29	JP¥789.00	-1.50%	11,800

Delayed Quote Japan Exchange

More quotes

Stock Market
Stocks
4896 Stock

The best tools reserved for subscribers to boost the performance of your investments!

Market Cap	8.72B 55.27M 49.11M 45.83M 41.77M 78.79M 5.31B 79.52M 555M 215M 2.72B 208M 203M	P/E 2024	-8.52x	P/E 2025	-7.71x
Enterprise Value	7.43B 47.08M 41.83M 39.04M 35.59M 67.12M 4.53B 67.74M 473M 183M 2.31B 177M 173M	EV / Sales 2024	-	EV / Sales 2025	-
Free-Float	33.99%	Yield 2024 *	-	Yield 2025	-

1 day	+1.60%
1 week	-4.87%
Current month	-5.11%
1 month	-6.96%
3 months	+7.02%
6 months	+2.42%
Current year	+15.45%

1 week	750	810
1 month	750	830
Current year	629	949
1 year	604	949
3 years	531	1,420
5 years	531	1,420
10 years	531	1,420

Manager	Title	Age	Since
Masaya Nakamura CTO	Chief Tech/Sci/R&D Officer	65	2016-10-31
Hideyuki Okano CTO	Chief Tech/Sci/R&D Officer	67	2016-10-31
Komei Fukushima PSD	President	66	2016-10-31

Director	Title	Age	Since
Komei Fukushima BRD	Director/Board Member	66	2016-10-31
Masato Matsumoto BRD	Director/Board Member	51	2021-09-30
Hideyuki Okano BRD	Director/Board Member	67	2019-09-30

K Pharma,Inc. Stock

Stocks

4896

JP3280900006

Pharmaceuticals

Valuation: K Pharma,Inc.

Chart: K Pharma,Inc.

Latest news: K Pharma,Inc.

Quotes and Performance

Price Extremes

Managers and Directors: K Pharma,Inc.

Other Pharmaceuticals

Financials

Company Profile

Quotes

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
K PHARMA,INC.	+1.60%	-4.87%	+13.56%	-	55.27M
ELI LILLY AND COMPANY	-0.61%	-3.43%	+36.07%	+115.04%	1,019B
JOHNSON & JOHNSON	-1.02%	-5.60%	+35.72%	+64.63%	617B
ABBVIE INC.	+1.11%	-0.58%	+12.36%	+77.95%	464B
MERCK & CO., INC.	+0.34%	-3.01%	+61.79%	+41.24%	356B
ROCHE HOLDING AG	-0.95%	-4.05%	+20.54%	+41.71%	333B
NOVARTIS AG	-1.46%	-2.89%	+10.57%	+32.81%	267B
ASTRAZENECA PLC	-1.35%	-5.43%	-6.17%	+8.98%	244B
AMGEN INC.	-1.04%	-2.79%	+35.30%	+51.84%	218B
GILEAD SCIENCES, INC.	-1.87%	-4.10%	+28.44%	+93.66%	179B
Average	-0.52%	-3.81%	+24.82%	+58.65%	369.72B
Weighted average by Cap.	-0.60%	-3.54%	+29.07%	+70.57%

	2024	2025
Net sales	-	-
Net income	-846M -5.36M -4.77M -4.45M -4.05M -7.65M -516M -7.72M -53.83M -20.86M -264M -20.14M -19.7M	-993M -6.3M -5.59M -5.22M -4.76M -8.97M -605M -9.06M -63.18M -24.48M -309M -23.64M -23.12M
Net Debt	-2.27B -14.38M -12.78M -11.92M -10.87M -20.5M -1.38B -20.69M -144M -55.92M -707M -53.99M -52.82M	-1.29B -8.19M -7.27M -6.79M -6.19M -11.67M -787M -11.78M -82.14M -31.83M -402M -30.73M -30.06M